Cargando…
ACTIVE TB AFTER THE USE OF TOCILIZUMAB FOR COVID-19 INFECTION
Autores principales: | NOH, SUNGRYONG, DRONAVALLI, GOUTHAM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Chest Physicians. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503030/ http://dx.doi.org/10.1016/j.chest.2021.07.295 |
Ejemplares similares
-
TB REACTIVATION FOLLOWING COVID-19 INFECTION
por: COLBY, STEVEN, et al.
Publicado: (2022) -
THE BAD AND THE UGLY: A CASE OF COVID-19 AND TB CO-INFECTION
por: AHMAD, SAAD, et al.
Publicado: (2021) -
INFECTIOUS COMPLICATIONS AFTER TOCILIZUMAB IN PATIENTS WITH COVID: A REAL-WORLD EXPERIENCE
por: LIU, HONGLI, et al.
Publicado: (2022) -
PULMONARY ASPERGILLOSIS POST-TOCILIZUMAB TREATMENT IN A PATIENT WITH COVID-19 PNEUMONIA
por: GIDWANI, VIPUL, et al.
Publicado: (2022) -
TB AND COVID-19 COINFECTION: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)